Lexicon Pharmaceuticals
LXRX
#7142
Rank
NZ$0.88 B
Marketcap
NZ$2.42
Share price
-1.41%
Change (1 day)
119.31%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - P/B ratio

P/B ratio as of December 2025 : 4.22

According to Lexicon Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 7.15372.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Lexicon Pharmaceuticals - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-311.92-52.4%
2023-12-314.0230.77%
2022-12-313.08-40.41%
2021-12-315.1666.88%
2020-12-313.09-17.83%
2019-12-313.77-114.14%
2018-12-31-26.6-274.31%
2017-12-3115.367.18%
2016-12-319.1489.45%
2015-12-314.82107.92%
2014-12-312.32-57.26%
2013-12-315.4327.86%
2012-12-314.25190.06%
2011-12-311.46-25.57%
2010-12-311.977.66%
2009-12-311.8386.81%
2008-12-310.9780-32.38%
2007-12-311.45-55.97%
2006-12-313.2919.62%
2005-12-312.75-32.18%
2004-12-314.0581.88%
2003-12-312.2352.71%
2002-12-311.46

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Eterna Therapeutics
ERNA
2.81-33.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
2.47-41.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
220 5,107.14%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1.69-60.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
4.21-0.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-1.94-145.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
8.34 97.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
3.86-8.46%๐Ÿ‡บ๐Ÿ‡ธ USA